Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-64667
Riklin, C; Seystahl, K; Hofer, S; Happold, C; Winterhalder, R; Weller, M (2012). Antiangiogenic treatment for multiple CNS hemangioblastomas. Onkologie, 35(7-8):443-445.
View at publisher
Background: Hemangioblastomas represent rare benign tumors of the central nervous system. In the case of metastatic spread and limited surgical options, systemic treatment may be considered. However there is no standard of care beyond surgery. Case Report: We report the cases of 2 patients with progressive multilocular hemangioblastomas, who showed clinical benefit and radiological stabilization of tumor growth after treatment with bevacizumab, an antibody against the vascular endothelial growth factor. Conclusion: Our case reports suggest activity of bevacizumab in hemangioblastomas after failure of standard therapeutic options.
139 downloads since deposited on 08 Oct 2012
45 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
|Dewey Decimal Classification:||610 Medicine & health|
|Deposited On:||08 Oct 2012 13:27|
|Last Modified:||02 Dec 2013 18:11|
|Additional Information:||© 2012 S. Karger AG|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page